Abstract:BACKGROUND:Randomized controlled trials are considered the gold standard for evaluating experimental treatments but often require large sample sizes. Single-arm trials require smaller sample sizes but are subject to bias when using historical control data for comparative inferences. This article presents a Bayesian adaptive synthetic-control design that exploits historical control data to create a hybrid of a single-arm trial and a randomized controlled trial.METHODS:The Bayesian adaptive synthetic control design has two stages. In stage 1, a prespecified number of patients are enrolled in a single arm given the experimental treatment. Based on the stage 1 data, applying propensity score matching and Bayesian posterior prediction methods, the usefulness of the historical control data for identifying a pseudo sample of matched synthetic-control patients for making comparative inferences is evaluated. If a sufficient number of synthetic controls can be identified, the single-arm trial is continued. If not, the trial is switched to a randomized controlled trial. The performance of The Bayesian adaptive synthetic control design is evaluated by computer simulation.RESULTS:The Bayesian adaptive synthetic control design achieves power and unbiasedness similar to a randomized controlled trial but on average requires a much smaller sample size, provided that the historical control data patients are sufficiently comparable to the trial patients so that a good number of matched controls can be identified in the historical control data. Compared to a single-arm trial, The Bayesian adaptive synthetic control design yields much higher power and much smaller bias.CONCLUSION:The Bayesian adaptive synthetic-control design provides a useful tool for exploiting historical control data to improve the efficiency of single-arm phase II clinical trials, while addressing the problem of bias when comparing trial results to historical control data. The proposed design achieves power similar to a randomized controlled trial but may require a substantially smaller sample size.

Introduction and Prospection of Minimization Random on Clinical Trials

The method of minimization for random allocation in clinical trials: introduction and its SAS program

The Application of Central Randomization System in Clinical Trials

The Balance Comparison among Simple Randomization, Stratified Blocked Randomization and Minimization

Statistical Inference of Adaptive Randomized Clinical Trials for Personalized Medicine

Mathematical programming tools for randomization purposes in small two‐arm clinical trials: A case study with real data

Mathematical programming tools for randomization purposes in small two-arm clinical trials: A case study with real data

BASIC: A Bayesian Adaptive Synthetic-Control Design for Phase II Clinical Trials.

A Bayesian Response-Adaptive Covariate-Balanced Randomization Design with Application to A Leukemia Clinical Trial

Asymptotic properties of covariate-adaptive randomization

Adaptive Allocation Theory in Clinical Trials

Bayesian Optimal Phase II Design for Randomized Clinical Trials

Subgroup identification in clinical trials: an overview of available methods and their implementations with R

Inference on Average Treatment Effect under Minimization and Other Covariate-Adaptive Randomization Methods

Exploring Statistical Methods in Clinical Trials When Some of the Patients are Treated against the Randomization

Multi-center clinical trials: Randomization and ancillary statistics

[Important statistical points for clinical research: from basics to applications]

Sequential monitoring of response-adaptive randomized clinical trials

A class of computational methods to reduce selection bias when designing Phase 3 clinical trials

Selecting a randomization method for a multi-center clinical trial with stochastic recruitment considerations

Theory on Covariate-Adaptive Randomized Clinical Trials: Efficiency, Selection bias and Randomization Methods